Vincenzo Nasca - Dissemin

All papers authored by Vincenzo Nasca

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2024 Giovanni Randon, Yoshiaki Nakamura, Rona Yaeger, Sara Lonardi, Chiara Cremolini, Elena Elez, Federico Nichetti, Filippo Ghelardi

, Vincenzo Nasca

, Francesca Bergamo, Veronica Conca, Javier Ros, Hideaki Bando, Giulia Maddalena, Simone Oldani and 7 other authors

Supplementary Figure S4 from Negative Hyperselection of Patients with HER2⁺ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study

Upload

Giovanni Randon, Yoshiaki Nakamura, Rona Yaeger, Sara Lonardi, Chiara Cremolini, Elena Elez, Federico Nichetti, Filippo Ghelardi

, Vincenzo Nasca

, Francesca Bergamo, Veronica Conca, Javier Ros, Hideaki Bando, Giulia Maddalena, Simone Oldani and 7 other authors

Supplementary Table S2 from Negative Hyperselection of Patients with HER2⁺ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study

Upload

Giovanni Randon, Yoshiaki Nakamura, Rona Yaeger, Sara Lonardi, Chiara Cremolini, Elena Elez, Federico Nichetti, Filippo Ghelardi

, Vincenzo Nasca

, Francesca Bergamo, Veronica Conca, Javier Ros, Hideaki Bando, Giulia Maddalena, Simone Oldani and 7 other authors

Supplementary Figure S1 from Negative Hyperselection of Patients with HER2⁺ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study

Upload

Giovanni Randon, Yoshiaki Nakamura, Rona Yaeger, Sara Lonardi, Chiara Cremolini, Elena Elez, Federico Nichetti, Filippo Ghelardi

, Vincenzo Nasca

, Francesca Bergamo, Veronica Conca, Javier Ros, Hideaki Bando, Giulia Maddalena, Simone Oldani and 7 other authors

Supplementary Table S1 from Negative Hyperselection of Patients with HER2⁺ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study

Upload

Giovanni Randon, Yoshiaki Nakamura, Rona Yaeger, Sara Lonardi, Chiara Cremolini, Elena Elez, Federico Nichetti, Filippo Ghelardi

, Vincenzo Nasca

, Francesca Bergamo, Veronica Conca, Javier Ros, Hideaki Bando, Giulia Maddalena, Simone Oldani and 7 other authors

Supplementary Figure S2 from Negative Hyperselection of Patients with HER2⁺ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study

Upload

Giovanni Randon, Yoshiaki Nakamura, Rona Yaeger, Sara Lonardi, Chiara Cremolini, Elena Elez, Federico Nichetti, Filippo Ghelardi

, Vincenzo Nasca

, Francesca Bergamo, Veronica Conca, Javier Ros, Hideaki Bando, Giulia Maddalena, Simone Oldani and 7 other authors

Supplementary Figure S3 from Negative Hyperselection of Patients with HER2⁺ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study

Upload

Giovanni Randon, Yoshiaki Nakamura, Rona Yaeger, Sara Lonardi, Chiara Cremolini, Elena Elez, Federico Nichetti, Filippo Ghelardi

, Vincenzo Nasca

, Francesca Bergamo, Veronica Conca, Javier Ros, Hideaki Bando, Giulia Maddalena, Simone Oldani and 7 other authors

Data from Negative Hyperselection of Patients with HER2⁺ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study

Upload

This paper was not found in any repository, but could be made available legally by the author.

2023 Filippo Ghelardi, Alessandra Raimondi, Federica Morano, Giovanni Randon, Alessandra Pannone, Marcello Guaglio, Giacomo Mazzoli, Vincenzo Nasca

, Massimo Milione, Giuseppe Leoncini, Giovanna Sabella, Gabriella Francesca Greco, Bianca Rosa Lampis, Margherita Galassi, Sara Delfanti and 6 other authors

Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin

Upload

This paper is made freely available by the publisher.

Valentina Fanotto

, Daniele Rossini, Mariaelena Casagrande, Francesca Bergamo, Andrea Spagnoletti, Daniele Santini, Carlotta Antoniotti, Samanta Cupini, Francesca Daniel, Vincenzo Nasca

, Guglielmo Vetere

, Alberto Zaniboni, Beatrice Borelli

, Martina Carullo

, Veronica Conca

and 5 other authors

Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies

Download from doi.org

Francesca Ligorio, Riccardo Lobefaro, Giovanni Fucà

, Leonardo Provenzano, Lucrezia Zanenga, Vincenzo Nasca

, Caterina Sposetti

, Giulia Salvadori, Angela Ficchì, Andrea Franza, Antonia Martinetti, Elisa Sottotetti, Barbara Formisano, Catherine Depretto, Gianfranco Scaperrotta and 6 other authors

Adding fasting‐mimicking diet to first‐line carboplatin‐based chemotherapy is associated with better overall survival in advanced triple‐negative breast cancer patients: A subanalysis of the NCT03340935 trial

Upload

Giovanni Randon

, Yoshiaki Nakamura

, Rona Yaeger

, Sara Lonardi

, Chiara Cremolini

, Elena Elez

, Federico Nichetti

, Filippo Ghelardi

, Vincenzo Nasca

, Francesca Bergamo

, Veronica Conca

, Javier Ros

, Hideaki Bando

, Giulia Maddalena

, Simone Oldani

and 7 other authors

Negative Hyperselection of Patients with HER2+ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study

Upload

Giovanni Randon, Yu Aoki, Romain Cohen

, Leonardo Provenzano, Vincenzo Nasca

, Samuel J. Klempner

, Steven B. Maron, Riccardo Cerantola, Joseph Chao, Lorenzo Fornaro, Walter Ferrari Bravo, Filippo Ghelardi, Margherita Ambrosini, Paolo Manca, Massimiliano Salati and 8 other authors

Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade

Download from doi.org

Vincenzo Nasca

, Francesco Barretta, Francesca Corti, Sara Lonardi

, Monica Niger, Maria Elena Elez, Marwan Fakih, Priya Jayachandran, Aakash Tushar Shah, Massimiliano Salati, Elisabetta Fenocchio, Lisa Salvatore

, Chiara Cremolini

, Javier Ros, Margherita Ambrosini and 5 other authors

Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer

Download from doi.org

2022 Vincenzo Nasca

, Anna Maria Frezza, Carlo Morosi, Ciriaco Buonomenna, Antonina Parafioriti, Giorgio Zappalà, Federica Bini, Paolo Giovanni Casali, Mattia Loppini, Silvia Stacchiotti

Rechallenge of denosumab in advanced giant cell tumor of the bone after atypical femur fracture: A case report and review of literature

Download from doi.org

2021 Carmine Carbone

, Geny Piro, Antonio Agostini

, Pietro Delfino, Francesco De Sanctis, Vincenzo Nasca

, Francesco Spallotta, Claudio Sette, Maurizio Martini, Stefano Ugel, Vincenzo Corbo, Paola Cappello

, Emilio Bria, Aldo Scarpa, Giampaolo Tortora

Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer

Download from doi.org

2020 Vincenzo Nasca

, Marta Chiaravalli, Geny Piro

, Annachiara Esposito, Lisa Salvatore

, Giampaolo Tortora, Vincenzo Corbo

, Carmine Carbone

Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification

Download from doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Vincenzo Nasca